This Article Full Text Full Text (PDF) All Versions of this Article: 200305-659OCv1 170/2/141    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cosío, B. G. Articles by Adcock, I. M. Search for Related Content PubMed PubMed Citation Articles by Cosío, B. G. Articles by Adcock, I. M.

Histone Acetylase and Deacetylase Activity in Alveolar Macrophages and Blood Mononocytes in Asthma

Department of Thoracic Medicine, National Heart and Lung Institute, Imperial College Faculty of Medicine, London, United Kingdom

Correspondence and requests for reprints should be addressed to Ian Adcock, Ph.D., Thoracic Medicine, National Heart and Lung Institute, Dovehouse Street, London SW3 6LY, UK. E-mail: ian.adcock{at}imperial.ac.uk

Histone acetylation status is a key factor in the regulation of inflammatory gene transcription. We investigated the activity of histone acetylases (HAT) and deacetylases (HDAC), and the effect of glucocorticoids in alveolar macrophages (AM) and peripheral blood mononuclear cells (PBMC) from subjects with asthma. Bronchoalveolar lavage was performed in 10 patients with intermittent asthma, 8 with persistent asthma, and 10 healthy control subjects. PBMCs and granulocytes were isolated from six patients with mild and severe asthma, before and after a 7-day course of prednisolone (30 mg/day). AMs were isolated for HDAC assay or incubated with dexamethasone (1 µM). HAT activity was increased (1.43 ± 0.1 vs. 1.01 ± 0.1 standard units/10 µg, p < 0.05), and HDAC activity was reduced (3,031 ± 243 vs. 5,004 ± 164 arbitrary fluorescence units/10 µg, p < 0.001) in AMs of subjects with asthma compared with control subjects. Dexamethasone suppressed LPS-induced granulocyte macrophage-colony stimulating factor, tumor necrosis factor-, and interleukin-8 release by 83 ± 1%, 51 ± 7% and 20 ± 9% (p < 0.001), respectively. Similar effects were seen on nuclear factor-B inhibition, and interleukin-8 release was further reduced by the HDAC enhancer, theophylline (37 ± 6%). Prednisolone increased HDAC activity in PBMCs from subjects with mild asthma. The increased inflammatory response in asthma may be due to reduced HDAC and enhanced HAT activity. Glucocorticoids and theophylline may downregulate the inflammatory response by modulating HAT and HDAC activity, and nuclear factor-B activation.

Key Words: inflammation • chromatin remodeling • theophylline • glucocorticoids • asthma

This article has been cited by other articles:

				D. A. Schwartz Epigenetics and Environmental Lung Disease Proceedings of the ATS, May 1, 2010; 7(2): 123 - 125. [Abstract] [Full Text] [PDF]

				P. Bhavsar, N. Khorasani, M. Hew, M. Johnson, and K. F. Chung Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma Eur. Respir. J., April 1, 2010; 35(4): 750 - 756. [Abstract] [Full Text] [PDF]

				A. M. Grabiec, S. Krausz, W. de Jager, T. Burakowski, D. Groot, M. E. Sanders, B. J. Prakken, W. Maslinski, E. Eldering, P. P. Tak, et al. Histone Deacetylase Inhibitors Suppress Inflammatory Activation of Rheumatoid Arthritis Patient Synovial Macrophages and Tissue J. Immunol., March 1, 2010; 184(5): 2718 - 2728. [Abstract] [Full Text] [PDF]

				M. Spears, I. Donnelly, L. Jolly, M. Brannigan, K. Ito, C. McSharry, J. Lafferty, R. Chaudhuri, G. Braganza, I. M. Adcock, et al. Effect of low-dose theophylline plus beclometasone on lung function in smokers with asthma: a pilot study Eur. Respir. J., May 1, 2009; 33(5): 1010 - 1017. [Abstract] [Full Text] [PDF]

				D. Adenuga, H. Yao, T. H. March, J. Seagrave, and I. Rahman Histone Deacetylase 2 Is Phosphorylated, Ubiquitinated, and Degraded by Cigarette Smoke Am. J. Respir. Cell Mol. Biol., April 1, 2009; 40(4): 464 - 473. [Abstract] [Full Text] [PDF]

				D. Pons, F. R. de Vries, P. J. van den Elsen, B. T. Heijmans, P. H.A. Quax, and J. W. Jukema Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease Eur. Heart J., February 1, 2009; 30(3): 266 - 277. [Abstract] [Full Text] [PDF]

				R. L. Miller and S.-m. Ho Epigenetic Studies Should Focus on Specific Cell Types Am. J. Respir. Crit. Care Med., October 15, 2008; 178(8): 883 - 883. [Full Text] [PDF]

				P Bhavsar, M Hew, N Khorasani, A Torrego, P J Barnes, I Adcock, and K F Chung Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma Thorax, September 1, 2008; 63(9): 784 - 790. [Abstract] [Full Text] [PDF]

				G. Braganza, R. Chaudhuri, and N. C. Thomson Review: Treating patients with respiratory disease who smoke Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 95 - 107. [Abstract] [PDF]

				K. Enya, H. Hayashi, T. Takii, N. Ohoka, S. Kanata, T. Okamoto, and K. Onozaki The interaction with Sp1 and reduction in the activity of histone deacetylase 1 are critical for the constitutive gene expression of IL-1{alpha} in human melanoma cells J. Leukoc. Biol., January 1, 2008; 83(1): 190 - 199. [Abstract] [Full Text] [PDF]

				H.R.S. Girn, N.M. Orsi, and S. Homer-Vanniasinkam An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease Vascular Medicine, November 1, 2007; 12(4): 299 - 309. [Abstract] [PDF]

				H. Dombrowsky and S. Uhlig Steroids and histone deacetylase in ventilation-induced gene transcription Eur. Respir. J., November 1, 2007; 30(5): 865 - 877. [Abstract] [Full Text] [PDF]

				N.-B. Nguyen, K. D. Callaghan, A. J. Ghio, D. J. Haile, and F. Yang Hepcidin expression and iron transport in alveolar macrophages Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L417 - L425. [Abstract] [Full Text] [PDF]

				S.-R. Yang, A. S. Chida, M. R. Bauter, N. Shafiq, K. Seweryniak, S. B. Maggirwar, I. Kilty, and I. Rahman Cigarette smoke induces proinflammatory cytokine release by activation of NF-{kappa}B and posttranslational modifications of histone deacetylase in macrophages Am J Physiol Lung Cell Mol Physiol, July 1, 2006; 291(1): L46 - L57. [Abstract] [Full Text] [PDF]

				K. Ito, S. Yamamura, S. Essilfie-Quaye, B. Cosio, M. Ito, P. J. Barnes, and I. M. Adcock Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-{kappa}B suppression J. Exp. Med., January 23, 2006; 203(1): 7 - 13. [Abstract] [Full Text] [PDF]

				S. Wenzel Severe Asthma in Adults Am. J. Respir. Crit. Care Med., July 15, 2005; 172(2): 149 - 160. [Abstract] [Full Text] [PDF]

				K. Ito, M. Ito, W. M. Elliott, B. Cosio, G. Caramori, O. M. Kon, A. Barczyk, S. Hayashi, I. M. Adcock, J. C. Hogg, et al. Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease N. Engl. J. Med., May 12, 2005; 352(19): 1967 - 1976. [Abstract] [Full Text] [PDF]

				L. Fabbri, S. P. Peters, I. Pavord, S. E. Wenzel, S. C. Lazarus, W. MacNee, F. Lemaire, and E. Abraham Allergic Rhinitis, Asthma, Airway Biology, and Chronic Obstructive Pulmonary Disease in AJRCCM in 2004 Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 686 - 698. [Full Text] [PDF]

				H. M. Wu, M. Jin, and C. B. Marsh Toward functional proteomics of alveolar macrophages Am J Physiol Lung Cell Mol Physiol, April 1, 2005; 288(4): L585 - L595. [Abstract] [Full Text] [PDF]

				P. J. Barnes, I. M. Adcock, and K. Ito Histone acetylation and deacetylation: importance in inflammatory lung diseases Eur. Respir. J., March 1, 2005; 25(3): 552 - 563. [Abstract] [Full Text] [PDF]